circular

DRUG2 trials

Sponsors

Rigshospitalet, Intra-Cellular Therapies Inc.

Conditions

APSAntiphospholipid antibodiesPsychosis associated with Alzheimer’s Disease

Phase 2

A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Efficacy, Safety, and Tolerability of ITI1284 in Patients with Psychosis Associated with Alzheimer’s Disease

RecruitingCTIS2024-513035-25-00

Intra-Cellular Therapies Inc.Psychosis associated with Alzheimer’s Disease

Start: 2025-07-11Target: 216Updated: 2026-01-21

Phase 3

HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibodies

RecruitingCTIS2023-504661-23-00

RigshospitaletAntiphospholipid antibodies, APS

Start: 2023-06-27Target: 300Updated: 2025-12-09